FDA Roundup: November 3, 2023
FDA Roundup: November 3, 2023 unknownFor Immediate Release:November 03, 2023
Today, the U.S. Food and Drug Administration is
FDA Updates for the Week of Oct. 2, 2023
FDA Updates for the Week of Oct. 2, 2023 unknown
Oncology Drug Exkivity to be Withdrawn from U.S. Market
FDA Encourages the Use of Decentralized Clinical Trials in New Draft Guidance
FDA Encourages the Use of Decentralized Clinical Trials in New Draft Guidance Foley & Lardner LLP
On May 2, 2023,
Virtual And Digital Health Digest - Healthcare - Worldwide
Virtual And Digital Health Digest - Healthcare - Worldwide unknown
To print this article, all you need is to be
FDA updates for Week of March 6, 2023
FDA updates for Week of March 6, 2023 unknown
FDA approves novel nasal spray for migraine.
The FDA has approved
FDA Updates for Week of Feb. 27, 2023
FDA Updates for Week of Feb. 27, 2023 unknown
FDA approves Kevzara for inflammatory rheumatic disease.
The FDA has approved
FDA Updates for Week of Feb. 20, 2023
FDA Updates for Week of Feb. 20, 2023 unknown
FDA approves weekly hemophilia A therapy.
The FDA has approved Altuviiio
FDA Updates for the Week of Feb. 6, 2023
FDA Updates for the Week of Feb. 6, 2023 unknown
FDA okays pediatric indication for Takeda’s Takhyzro
The FDA
FDA Updates for the Week of Jan 30, 2023
FDA Updates for the Week of Jan 30, 2023 unknown
FDA approves Trodelvy for HR+/HER2- breast cancer.
The FDA
FDA Updates for the Week of Jan. 23, 2023
FDA approves Lilly’s BTK inhibitor for rare blood cancer.
The FDA has granted accelerated approval to Lilly’s Jaypirca